miR-6833-3p Promotes Prostate Cancer Progression via NUMB-NOTCH Pathway Inhibition
miR-6833-3p drives prostate cancer progression by inhibiting the NUMB-mediated NOTCH signaling pathway.
Asset / Drug
Drug and asset intelligence for miR-6833-3p with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.